SRK-001

N/A

Report date: 2022/12/31 20:28:45

Base Information

Drug NameSRK-001
Drug Alias NameSRK-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionInflammasomes inhibitors
TargetsInflammasomes
Therapy Area/IndicationsLupus Erythematosus, Systemic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryNetherlands
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSarkana Pharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesSarkana Pharma Inc
Inactive CompaniesN/A
Active IndicationsLupus Erythematosus, Systemic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A